Effect of Vitamin D3 Supplementation on Cardiac Autonomic Nerve Function in Male Epileptic Patients With Hypovitaminosis D

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to see the effect of vitamin D3 supplementation on cardiac autonomic nerve function in male epileptic patients with hypovitaminosis D that weather vitamin D improves heart rate variability or not. The main questions it aims to answer are: 1. Does vitamin D improves cardiac autonomic tone in male epileptic patients? 2. Does vitamin D improves heart rate variability in male epileptic patients? It is a self control trial. Participants will: 1. undergo through baseline HRV testing 2. start to take vitamin D3 50000 IU once in a week for 8 weeks b) visit the university after 8 weeks for post interventional HRV testing . Researcher will compare the pre test and post test value of HRV testing.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 20
Maximum Age: 40
Healthy Volunteers: f
View:

• • Diagnosed male patients with Epilepsy by neurologist from the OPD of Department of Neurology by taking proper history of at least two unprovoked (or reflex) seizures occuring \> 24 hours apart, from patients and eye witnesses.

‣ Having hypovitaminosis D (serum vitamin D3 level \<30 ng/ml)

⁃ Age: 20-40 years.

• Sex: Male

∙ BMI : 18.5-24.9 kg/m2

∙ Taking antiepileptic drug for 6 months to 2 years ( Enzyme inducer AEDs, e.g. Carbamazepine, Phenytoin, Phenobarbital)

∙ Without medication that affect central nervous system other than antiepileptic drugs (AEDs).

Locations
Other Locations
Bangladesh
Bangladesh Medical University
RECRUITING
Dhaka
Contact Information
Primary
Registrar, BMU
registrar@bsmmu.edu.bd
+88 02 55165708
Time Frame
Start Date: 2025-07
Estimated Completion Date: 2025-10
Participants
Target number of participants: 15
Treatments
Experimental: 15 male epileptic patients with hypovitaminosis D
15 male epileptic patients with hypovitaminosis D will be enrolled. They will be supplemented with Vitamin D orally 50,000 IU/week for 8 weeks
Related Therapeutic Areas
Sponsors
Leads: Bangladesh Medical University

This content was sourced from clinicaltrials.gov